Sunil Healthcare Limited (BOM:537253)

Market Cap	707.58M
Revenue (ttm)	878.28M
Net Income (ttm)	17.28M
Shares Out	10.25M
EPS (ttm)	1.69
PE Ratio	40.95
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Average Volume	745
Open	69.00
Previous Close	69.00
Day's Range	69.00 - 69.00
52-Week Range	60.55 - 94.90
Beta	-0.22
RSI	41.10
Earnings Date	Feb 3, 2026

About Sunil Healthcare

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul ...

• Industry: Miscellaneous Chemical Products
• Founded: 1973
• Employees: 161
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 537253

Financial Performance

In 2024, Sunil Healthcare's revenue was 834.21 million, a decrease of -7.51% compared to the previous year's 901.92 million. Losses were -14.17 million, -20.79% less than in 2023.